BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24880700)

  • 1. Longitudinal association between BMI at diagnosis and HIV disease progression.
    Johnson KD; Cai B; Duffus W; White K; Smieja M; Divya A; Merchant AT
    AIDS Behav; 2014 Nov; 18(11):2249-57. PubMed ID: 24880700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort.
    Jones CY; Hogan JW; Snyder B; Klein RS; Rompalo A; Schuman P; Carpenter CC;
    Clin Infect Dis; 2003; 37 Suppl 2():S69-80. PubMed ID: 12942377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.
    Guehi C; Badjé A; Gabillard D; Ouattara E; Koulé SO; Moh R; Ekouevi D; Ahibo H; N'Takpé JB; Menan GK; Deschamps N; Lecarrou J; Eholié S; Anglaret X; Danel C
    AIDS Res Ther; 2016; 13():12. PubMed ID: 26925155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
    Paton NI; Sangeetha S; Earnest A; Bellamy R
    HIV Med; 2006 Jul; 7(5):323-30. PubMed ID: 16945078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on weight and height with the use of HAART in HIV-infected children.
    Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
    Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of weight on immune cell counts among HIV-infected persons.
    Crum-Cianflone NF; Roediger M; Eberly LE; Ganesan A; Weintrob A; Johnson E; Agan BK;
    Clin Vaccine Immunol; 2011 Jun; 18(6):940-6. PubMed ID: 21525303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients.
    Tedaldi EM; Brooks JT; Weidle PJ; Richardson JT; Baker RK; Buchacz K; Moorman AC; Wood KC; Holmberg SD;
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):35-41. PubMed ID: 16885779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index, immune status, and virological control in HIV-infected men who have sex with men.
    Blashill AJ; Mayer KH; Crane HM; Grasso C; Safren SA
    J Int Assoc Provid AIDS Care; 2013; 12(5):319-24. PubMed ID: 23719237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in nutritional, functional and immunological status of HIV-infected adults with antiretroviral therapy.
    Tafese Z; Berhan Y; Abebe H
    Ethiop Med J; 2012 Jan; 50(1):75-87. PubMed ID: 22519164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.
    Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD;
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):50-8. PubMed ID: 26352511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and obesity: where did all the wasting go?
    Tate T; Willig AL; Willig JH; Raper JL; Moneyham L; Kempf MC; Saag MS; Mugavero MJ
    Antivir Ther; 2012; 17(7):1281-9. PubMed ID: 22951353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
    Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
    Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional care, time period since diagnosis, demographics and body mass index in HIV/AIDS patients.
    Núñez-Rocha GM; Wall KM; Chávez-Peralta M; Salinas-Martínez AM; Benavides-Torres RA
    Rev Invest Clin; 2013; 65(4):291-9. PubMed ID: 24304729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.
    Brennan AT; Berry KM; Rosen S; Stokes A; Crowther NJ; George J; Raal F; Cassim N; Sanne I; Long L; Fox MP
    AIDS; 2019 Nov; 33(13):2049-2059. PubMed ID: 31577571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and immune cell counts in women.
    Womack J; Tien PC; Feldman J; Shin JH; Fennie K; Anastos K; Cohen MH; Bacon MC; Minkoff H
    Metabolism; 2007 Jul; 56(7):998-1004. PubMed ID: 17570264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.